glp 1 not overweight GLP-1 If Overweight: Biomarker & Clinical Criteria – PlexusDx The GLP-1 Agonists and Obesity:
Description
they do not overinflate
GLP-1 side effects can amplify those changes
The Precision Peptide Genetic Test identifies variants in key peptide pathway genes (GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) that may relate to baseline appetite regulation and potential responsiveness markers
Noom's new program addresses these root causes proactively
Conclusion We expect payer views on obesity and coverage of GLP-1s to evolve over the next 5 years, likely leading to a more favorable access environment
